Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Division of Cardiac Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Eur J Heart Fail. 2021 Aug;23(8):1404-1415. doi: 10.1002/ejhf.2215. Epub 2021 May 31.
Infections are common following left ventricular assist device (LVAD) implantation and predict adverse events. Infections are frequent prior to LVAD implantation although their impact on postoperative outcomes remains unknown. Gut and nasal microbial imbalance may predispose to mucosal colonization with pathogens. Herein, we investigated the predictive role of pre-LVAD infections, and explored the association of nasal Staphylococcus aureus (SA) colonization and gut microbiota, on postoperative outcomes.
Overall, 254 LVAD patients were retrospectively categorized based on pre-LVAD infection status: Group 1, bacterial/fungal bloodstream infection (BSI); Group 2, other bacterial/fungal; Group 3, viral; and Group 4, no infection. In a subset of patients, nasal SA colonization (n = 140) and pre-LVAD stool (n = 25) were analysed using 16S rRNA sequencing. A total of 75 (29%) patients had a pre-LVAD infection [Group 1: 22 (29%); Group 2: 41 (55%); Group 3: 12 (16%)]. Pre-LVAD BSIs were independent predictors of 1-year postoperative mortality and infections [Group 1 vs. 4: hazard ratio (HR) 2.70, P = 0.036 vs. HR 1.8, P = 0.046]. In an unadjusted analysis, pre-LVAD infections other than BSIs, INTERMACS profile ≤2, higher serum creatinine, lower serum albumin and nasal SA colonization were also significantly associated with postoperative infections. Patients with early post-LVAD infections exhibited decreased microbial diversity (P < 0.05).
Pre-LVAD infections are common. BSIs independently predict postoperative mortality and infections. Additional studies are needed to confirm our findings that pre-LVAD SA nasal colonization and gut microbial composition can help stratify patients' risk for infectious complications after LVAD implantation.
左心室辅助装置(LVAD)植入后常发生感染,并预测不良事件。尽管感染在 LVAD 植入前很常见,但它们对术后结果的影响仍不清楚。肠道和鼻腔微生物失衡可能使粘膜更容易被病原体定植。在此,我们研究了 LVAD 植入前感染的预测作用,并探讨了鼻金黄色葡萄球菌(SA)定植和肠道微生物群与术后结果的关联。
总体而言,根据 LVAD 植入前感染状况,对 254 例 LVAD 患者进行回顾性分类:第 1 组,细菌/真菌感染性血流感染(BSI);第 2 组,其他细菌/真菌感染;第 3 组,病毒感染;第 4 组,无感染。在部分患者中,采用 16S rRNA 测序分析鼻 SA 定植(n=140)和 LVAD 植入前粪便(n=25)。共有 75 例(29%)患者存在 LVAD 植入前感染[第 1 组:22 例(29%);第 2 组:41 例(55%);第 3 组:12 例(16%)]。LVAD 植入前 BSI 是术后 1 年死亡和感染的独立预测因素[第 1 组与第 4 组:风险比(HR)2.70,P=0.036 比 HR 1.8,P=0.046]。在未调整的分析中,除 BSI 外的 LVAD 植入前感染、INTERMACS 评分≤2、血清肌酐升高、血清白蛋白降低和鼻 SA 定植也与术后感染显著相关。早期 LVAD 感染患者的微生物多样性降低(P<0.05)。
LVAD 植入前感染很常见。BSI 独立预测术后死亡和感染。需要进一步研究来证实我们的发现,即 LVAD 植入前鼻金黄色葡萄球菌定植和肠道微生物组成可以帮助分层患者感染并发症的风险。